In a study aimed at identifying pancreatic CSCs in tissue samples derived from patients, it was demonstrated that at the invading front of pancreatic tumors, CSCs, as defined by the presence of CD133+, also expressed CXCR4. This evidence concerns the gene CXCR4 and pancreatic neoplasm.